Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
CONCLUSIONS: Although live vaccinations were safe and sufficiently immunogenic in most studies, some serious reactions and vaccine-related infections were reported in immunosuppressed IMID and SOT patients. Apart from mild vaccine-related infections MMR and VV vaccines were safe when administered less than two years after BMT.
IMPLICATIONS OF KEY FINDINGS: Until further data are available, live vaccinations under most immunosuppressive treatments should only be administered after a careful risk benefit assessment of medications and dosages.
FUNDING: None.
PMID: 28162821 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Croce E, Hatz C, Jonker EF, Visser LG, Jaeger VK, Bühler S Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Bone Marrow Transplant | Databases & Libraries | Dexamethasone | Herpes | Measles | Measles Vaccine | Mumps | Mumps Vaccine | Polio | Polio Vaccine | Pregnancy | Remicade | Rotavirus | Rotavirus Vaccine | Rubella | Rubella Vaccine | Shingles (Herpes Zoster) Vaccine | Smallpox | Smallpox Vaccine | Study | Transplants | Tuberculosis (BCG) Vaccine | Typhoid | Typhoid Vaccine | Vaccines | Varicella-Zoster Virus Vaccine | Yellow Fever | Yellow Fever Vaccination